Neuropathic Pain and Itch Mechanisms Underlying Allergic Conjunctivitis
- PMID: 30222114
- DOI: 10.18176/jiaci.0320
Neuropathic Pain and Itch Mechanisms Underlying Allergic Conjunctivitis
Abstract
Objective: Among the constellation of symptoms that characterizes allergic conjunctivitis, many (eg, burning and stinging) can be attributed to chronic neuropathic pain. Cumulative data support that these hallmark symptoms might be linked to the effects of allergen-induced neuromodulation. This review investigates the key characteristics of neuropathic itch and pain in allergic conjunctivitis and their underlying pathogenic mechanisms.
Methods: A literature review was conducted using a PubMed search focusing on allergic conjunctivitis, neurogenic inflammation, neuropathic itch, and neuropathic pain. Articles were reviewed, and those discussing clinical course, pathophysiology, and neuronal regulation of chronic neuropathic symptoms as related to allergic disease were summarized.
Results: Recent evidence suggests that some symptoms of allergic conjunctivitis may be better represented as a chronic neuropathic disorder. We found that neurogenic mechanisms may have a significant role in chronic ocular surface inflammation from allergic inflammation. Manifestations may be associated with repeated ocular sensory nerve injury leading to an acute-to-chronic transition, which is in turn associated with neuropathologic changes (peripheral and central sensitization), neuronal dysfunction, and spontaneous ocular pain.
Conclusion: Current goals in the management of allergic conjunctivitis aim to minimize the inflammatory cascade associated with the allergic response in the initial stages of the pathogenic mechanism. Based on the mechanistic data reviewed herein, the recognition that neuronal inflammation explains many of the symptoms in allergic conjunctivitis opens new frontiers for drug discovery.
Keywords: Allergic conjunctivitis; Dry eye; Nerve growth factor (NGF); Neuronal dysfunction; Neuropathic pain; Sensitization; Substance P (SP); Transient receptor potential ankyrin 1 (TRPA1); Transient receptor potential vanilloid 1 (TRPV1).
Similar articles
-
Neuropathic pain and itch: mechanisms in allergic conjunctivitis.Curr Opin Allergy Clin Immunol. 2022 Oct 1;22(5):298-303. doi: 10.1097/ACI.0000000000000843. Epub 2022 Jul 27. Curr Opin Allergy Clin Immunol. 2022. PMID: 35916592 Review.
-
Burning Eye Syndrome: Do Neuropathic Pain Mechanisms Underlie Chronic Dry Eye?Pain Med. 2016 Apr;17(4):746-55. doi: 10.1093/pm/pnv070. Epub 2015 Dec 24. Pain Med. 2016. PMID: 26814296 Free PMC article. Review.
-
Clinical presentation, management, and pathophysiology of neuropathic itch.Lancet Neurol. 2018 Aug;17(8):709-720. doi: 10.1016/S1474-4422(18)30217-5. Epub 2018 Jul 17. Lancet Neurol. 2018. PMID: 30033061 Review.
-
Neuronal FcεRIα directly mediates ocular itch via IgE-immune complex in a mouse model of allergic conjunctivitis.J Neuroinflammation. 2022 Feb 23;19(1):55. doi: 10.1186/s12974-022-02417-x. J Neuroinflammation. 2022. PMID: 35197064 Free PMC article.
-
Neuropathic symptoms of the ocular surface: dryness, pain, and itch.Curr Opin Allergy Clin Immunol. 2017 Oct;17(5):373-381. doi: 10.1097/ACI.0000000000000389. Curr Opin Allergy Clin Immunol. 2017. PMID: 28858914 Free PMC article. Review.
Cited by
-
Licochalcone A inhibits IgE-mediated allergic reaction through PLC/ERK/STAT3 pathway.Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221135462. doi: 10.1177/03946320221135462. Int J Immunopathol Pharmacol. 2022. PMID: 36263976 Free PMC article.
-
MiR-146a upregulates FOXP3 and suppresses inflammation by targeting HIPK3/STAT3 in allergic conjunctivitis.Ann Transl Med. 2022 Mar;10(6):344. doi: 10.21037/atm-22-982. Ann Transl Med. 2022. PMID: 35434020 Free PMC article.
-
TRPV1 in Pain and Itch.Adv Exp Med Biol. 2021;1349:249-273. doi: 10.1007/978-981-16-4254-8_12. Adv Exp Med Biol. 2021. PMID: 35138618
-
Knowledge attitude and practice of patients with allergic conjunctivitis towards their disease.Sci Rep. 2025 Feb 20;15(1):6238. doi: 10.1038/s41598-025-87518-2. Sci Rep. 2025. PMID: 39979330 Free PMC article.
-
Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitis.J Allergy Clin Immunol Glob. 2024 Jul 31;3(4):100317. doi: 10.1016/j.jacig.2024.100317. eCollection 2024 Nov. J Allergy Clin Immunol Glob. 2024. PMID: 39253106 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials